Publicaciones en colaboración con investigadores/as de Hospital Infantil Universitario Niño Jesus de Madrid (53)

2024

  1. Delphi consensus on the transition from paediatric to adult epilepsy care

    Neurology Perspectives, Vol. 4, Núm. 2

  2. Palliative care for children with central nervous system tumors: results of a Spanish multicenter study

    Clinical and Translational Oncology, Vol. 26, Núm. 3, pp. 786-795

2023

  1. Adolescent cancer care: What has changed in Spain in the past decade?

    Anales de Pediatria, Vol. 98, Núm. 2, pp. 129-135

  2. Characteristics and management of patients with SARS-CoV2 infection admitted to pediatric intensive care units: Data analysis of the Spanish national multicenter registry

    Pediatric Pulmonology, Vol. 58, Núm. 10, pp. 2916-2929

  3. ClinPrior: an algorithm for diagnosis and novel gene discovery by network-based prioritization

    Genome medicine, Vol. 15, Núm. 1, pp. 68

  4. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain

    European Journal of Pediatrics, Vol. 182, Núm. 1, pp. 307-317

  5. Multicentre Delphi study of physicians resulted in quality indicators for young infants with fever without source in emergency departments

    Acta Paediatrica, International Journal of Paediatrics, Vol. 112, Núm. 9, pp. 1962-1969

  6. Opsoclonus-myoclonus syndrome: clinical characteristics, therapeutic considerations, and prognostic factors in a Spanish paediatric cohort

    Neurologia, Vol. 38, Núm. 2, pp. 93-105

  7. Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis

    European Journal of Pediatrics, Vol. 182, Núm. 9, pp. 4271-4284

  8. Setting priorities for an agenda within the Spanish pediatric emergency medicine research network

    European Journal of Pediatrics, Vol. 182, Núm. 8, pp. 3549-3558

2022

  1. Correction to: Position statement of the Spanish society of pediatric rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: part 1 (screening) (European Journal of Pediatrics, (2022), 181, 6, (2343-2354), 10.1007/s00431-022-04418-7)

    European Journal of Pediatrics

  2. Diagnosis of Genetic White Matter Disorders by Singleton Whole-Exome and Genome Sequencing Using Interactome-Driven Prioritization

    Neurology, Vol. 98, Núm. 9, pp. E912-E923

  3. Effect of the SARS-CoV-2 pandemic on the control and severity of pediatric asthma

    Allergologia et Immunopathologia, Vol. 50, Núm. 1, pp. 99-103

  4. Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries – A study by the Joint Action on Rare Cancers

    Cancer Epidemiology, Vol. 78

  5. Onset of Nut Allergy in a Pediatric Cohort: Clinical and Molecular Patterns in the AFRUSEN Study

    Journal of investigational allergology & clinical immunology, Vol. 32, Núm. 4, pp. 270-281

  6. Venous thromboembolism in pediatric patients with acute lymphoblastic leukemia under chemotherapy treatment. Risk factors and usefulness of thromboprophylaxis. Results of LAL-SEHOP-PETHEMA-2013

    Journal of Thrombosis and Haemostasis, Vol. 20, Núm. 6, pp. 1390-1399

2021

  1. Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain

    Journal of Medical Economics, Vol. 24, Núm. 1, pp. 628-636

  2. Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH)

    European Journal of Haematology, Vol. 106, Núm. 6, pp. 842-850

  3. Febrile young infants with abnormal urine dipstick at low risk of invasive bacterial infection

    Archives of Disease in Childhood, Vol. 106, Núm. 8, pp. 758-763

  4. Improved collection of hematopoietic stem cells and progenitors from Fanconi anemia patients for gene therapy purposes

    Molecular Therapy - Methods and Clinical Development, Vol. 22, pp. 66-75